Core Oncology Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Core Oncology General Information

Description

Developer of cancer treatment systems designed to treat cancers. The company's cancer treatment systems offers iodine I-125 and palladium Pd-103 brachytherapy seeds, isoloader and a physics workstation that automates brachytherapy needle loading, radioactive seed assay and reporting, enabling doctors to treat cancers and help patients to recover the same.

Contact Information

Formerly Known As
Brachysales Inc.
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 7525 South East 24th Street
  • Suite 650
  • Mercer Island, WA 98040
  • United States
+1 (206)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Corporate Office
  • 7525 South East 24th Street
  • Suite 650
  • Mercer Island, WA 98040
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Core Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2012 Completed Out of Business
1. Early Stage VC 22-Jun-2009 Completed Startup
To view Core Oncology’s complete valuation and funding history, request access »

Core Oncology Patents

Core Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2010124022-A1 Brachytherapy fiducial needle fixation system and method Inactive 21-Apr-2009
US-20100056842-A1 Brachytherapy multiple implantation device loading tray and method Inactive 29-Aug-2008
WO-2010025396-A1 Brachytherapy multiple implantation device loading tray and method Inactive 29-Aug-2008
US-20060063960-A1 Radiation shielding device Active 13-Aug-2004
US-20090057580-A1 Radiation shielding device Active 13-Aug-2004 A61N5/1027
To view Core Oncology’s complete patent history, request access »

Core Oncology Acquisitions (1)

Core Oncology’s most recent deal was a Merger/Acquisition with Mills Biopharmaceuticals. The deal was made on 12-Jun-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mills Biopharmaceuticals 12-Jun-2007 Merger/Acquisition Other Healthcare Services
To view Core Oncology’s complete acquisitions history, request access »

Core Oncology FAQs

  • When was Core Oncology founded?

    Core Oncology was founded in 2007.

  • Where is Core Oncology headquartered?

    Core Oncology is headquartered in Mercer Island, WA.

  • What industry is Core Oncology in?

    Core Oncology’s primary industry is Other Healthcare Technology Systems.

  • Is Core Oncology a private or public company?

    Core Oncology is a Private company.

  • What is Core Oncology’s current revenue?

    The current revenue for Core Oncology is .

  • How much funding has Core Oncology raised over time?

    Core Oncology has raised $5.11M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process